Neurocrine Biosciences initiates Phase 2 study of NBI-'567 in adults with Alzheimer's disease
NBIX•Neurocrine Biosciences initiated a Phase 2 clinical study evaluating NBI-'567 in adults with Alzheimer's disease.
1. Phase 2 study
Neurocrine Biosciences initiated a Phase 2 clinical study evaluating NBI-'567 in adults with Alzheimer's disease.
